Instytut Pomnik Centrum Zdrowia Dziecka

At Instytut Pomnik Centrum Zdrowia Dziecka, a major focus is on digestive system diseases and immune system disorders, especially pediatric Crohn's disease and ulcerative colitis. The trials are designed to assess new and existing therapies that may help control inflammation, improve remission rates, and support safer long-term care for children and adolescents.

• Moderately to severely active Crohn's disease and ulcerative colitis
• Inflammatory bowel diseases with a focus on treatment effectiveness and safety
• Complex perianal fistulas associated with Crohn's disease

Research in this area includes evaluating therapies for symptom control, remission, and broader disease management in young patients.

The site also contributes to studies in nervous system diseases, with attention to relapsing-remitting multiple sclerosis in children and adolescents. These trials aim to better understand treatment response, monitor safety, and support more effective management of chronic neurological illness.

• Relapsing-remitting multiple sclerosis in pediatric patients
• Evaluation of treatment effectiveness and safety in neurologic disorders
• Studies of how therapies behave in children and adolescents

This research reflects the department’s strength in pediatric neurology and its interest in improving care for complex long-term conditions.

Clinical trials at the Warsaw site include nutritional and metabolic diseases, particularly type 1 diabetes mellitus. The research is centered on preserving natural insulin production and evaluating whether new approaches can improve disease control soon after diagnosis.

• Type 1 diabetes mellitus in newly diagnosed children and adolescents
• Testing strategies to preserve endogenous insulin secretion
• Assessing treatment benefit alongside standard diabetes care

These studies aim to support better long-term outcomes for young people living with diabetes.

Another important theme is congenital, hereditary, and neonatal diseases, including biliary atresia. The trials in this field are focused on supporting liver health and examining whether new treatments can help improve survival and long-term outcomes in children with rare conditions.

• Biliary atresia and related pediatric liver disease
• Evaluation of therapies aimed at improving native liver survival
• Research on treatment durability and ongoing safety

This line of research addresses serious early-life disorders where effective treatment options are especially important.

The clinical portfolio also spans respiratory tract diseases and advanced diagnostic techniques, including work in pulmonary arterial hypertension and pediatric contrast-enhanced magnetic resonance imaging. These studies are intended to improve disease monitoring, test supportive therapies, and refine diagnostic performance in children.

• Pulmonary arterial hypertension in pediatric patients
• Research on treatment added to standard care to slow disease progression
• Imaging studies assessing safety and body handling of contrast agents in children

By combining therapeutic and diagnostic research, the Institute of the Memorial Health Institute for Children supports more precise pediatric care across several complex conditions.